Supplementary table 2. Five patients experienced at least grade 2 adverse events. Two of the 5 patients received at least 4 cycles of treatment, and the associated adverse events were noted after cycle 1. All cytopenias resolved prior to the completion of the cycle that adverse event occurred. Abbreviations: DL = dose level, m-protein = monoclonal protein, CXDX = cycle X, day X, NA = not available.